Health24.com | Malaria still kills 1 100 a day. It can’t afford to lose resources to coronavirus

Today, another 1 100 people will die from malaria. The number will be repeated tomorrow, and the day after.

As a public health researcher, I embrace the idea that all lives have equal value. That our goal is much more to delay death than to stop death, as the latter is inevitable. Therefore as we mark this year’s World Malaria Day, we must emphasise the need for stronger health systems and sustained investments to tackle malaria more aggressively.

This message needs to be conveyed even more urgently than usual amid the coronavirus pandemic. Given the situation in Europe, China and the US, it is clear that Covid-19 significantly disrupts health systems and economic growth. There is genuine fear that if it continues spreading in Africa, the impact may be worse given the continent’s weaker health systems. One of the greatest concerns is the likely shift of attention and resources from control programmes of other infections, such as malaria.

Since 2000, Africa has benefited from some of the greatest efforts against malaria. This included a global coalition that has delivered more than 2 billion insecticide-treated nets to countries where malaria is endemic.

Given the extensive health gains, experts increasingly embraced the idea that malaria eradication, though ambitious, is both a feasible and a necessary goal. This remains the aim.

Recently, a strategic advisory panel set up by the World Health Organisation (WHO) five years ago released a report of a three-year study on benefits, future scenarios and feasibility of malaria elimination. Among its key recommendations is improved access to high-quality people-centred health services, adequate financing and resourcing for malaria programmes as well as stronger engagement with communities.

Unfortunately, in the context of Covid-19, many of these recommendations will be unattainable in the short and medium term. Resources will be shifted to tackle the pandemic and community engagement initiatives will be reduced to a bare minimum to achieve social distancing. Moreover, access to health facilities may be reduced for people with other common diseases such as malaria.

This will mean there will be many more deaths from malaria and other diseases.

This has happened before. Evidence from Africa’s fight against Ebola suggests that during outbreaks, many more people are indirectly killed by other diseases such as malaria, HIV and tuberculosis than by the outbreak itself.

African health authorities must therefore earnestly guard against such outcomes, and create a more rational response.

Protecting gains made against malaria

The past 20 years have seen major scientific developments. These have led to malaria deaths being cut from over 1 million to 405 000 a year.

This has been due in part to advances in treatments. Artemisinin-based treatments have replaced previous mono-therapies such as chloroquine. The new drugs have remained effective across Africa, which has largely been unaffected by treatment failures such as those observed in south-east Asia. About 4 million doses of child formulations of these treatments have been delivered, saving another 850 000 lives.

There have also been advances in prevention measures. For example, to mitigate the threat of insecticide resistance in malaria mosquitoes, scientists from private and public institutions have created new types of insecticidal bed nets and new chemical formulations for spraying houses. And countries such as Tanzania are using innovative distribution approaches involving schools so that they can maintain high coverage and access to essential malaria commodities.

But African countries don’t have resilient communities and strong health systems. This means that these past gains need to be protected vigorously.

Not all fevers are Covid-19

Initial symptoms of malaria – such as a high fever – may be similar to those of influenza and other viral infections such as Covid-19.

This underscores the need for malaria programme managers, community leaders and health workers in affected communities to continue to emphasise prompt diagnosis, effective treatment and improved prevention. But health workers and communities should not be put at any risk. Therefore essential information should be provided about both malaria and Covid-19.

In addition, special efforts will need to be made to avert indirect deaths. For example during the Ebola outbreak, a mass drug rollout was put in place in Sierra Leone to prevent malaria deaths.

Similarly, countries will require innovative approaches to ensure continued distribution of insecticide treated nets. The WHO has already sent an advisory to malaria-endemic countries on how to tailor their control efforts during the Covid-19 pandemic. Without this, Africa will bear the combined consequences of both diseases.

Since zero malaria starts with each one of us, we must keep up the malaria fight through this cloud of Covid-19.The Conversation

Fredros Okumu, Director of Science, Ifakara Health Institute

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Image credit: iStock

Share Button

Health24.com | Coronavirus morning update: Revised national budget, SA cases surge past 4 000, and Trump under fire

WHAT’S HAPPENING IN SA

Cases update: 

The latest number of confirmed cases is 4 220.

According to the latest update, 79 deaths have been recorded in the country.

So far, 152 390 tests have been conducted, with more than 8 800 new tests conducted.

READ MORE |All the confirmed cases of coronavirus in SA

Latest news:

Minister of Finance Tito Mboweni said on Friday that he would table a revised budget to Parliament which would accommodate government’s R800 billion response to the Covid-19 coronavirus pandemic.

“I will be shortly tabling a revised budget bill before Parliament to deal with all of these measures,” Mboweni said at a press briefing. He did not specify a date. 

Earlier in the week, President Cyril Ramaphosa announced the R500 billion coronavirus relief package, which included stimulus funds, allocations for salary cover and tax incentives for businesses affected by Covid-19 and the lockdown.

Mboweni said the relief package, combined with monetary policy measures from the South African Reserve Bank such as the 200 basis point cut in interest rates in less than a month, could unlock as much as R800 billion into the economy.

Without detailing the strategy in depth, Mboweni said the national budget that he tabled in February would undergo budget reallocation and reprioritisation to ensure that funds are redirected from non-essential state functions to the government’s interventions to the coronavirus.

READ MORE | Mboweni to table adjusted budget outlining coronavirus relief package

President Cyril Ramaphosa has heaped praise on Gauteng for its state-of-readiness in the midst of the increasing number of Covid-19 cases in the country.

Ramaphosa joined Premier David Makhura and Health MEC Bandile Masuku for a tour of three of the province’s facilities on Friday, which included a field hospital set up at the Nasrec expo centre, a food bank and Charlotte Maxeke Hospital.

He praised the provincial government and healthcare workers leading its response to the deadly pandemic, saying they have shown great dedication, commitment and sacrifice.

“The question of financial resources becomes easy when a province demonstrates innovation and is being far-sighted, [showing] foresight and in many ways really working hard to make sure it safeguards the life as well as the health of the people of this province.”

He said the hospital, which currently has 19 intensive care units, would be ramped up by 100.

“That is phenomenal, and in many ways this hospital, through the Covid crisis, [is] being transformed to be ready for NHI [National Health Insurance], and we are putting the building blocks in place,” he added, referring to the country’s vision of universal health care.

READ MORE | Covid-19 crisis is helping SA hospitals get ready for NHI – Ramaphosa

More than 220 000 South African workers may be due a total not far from R1 billion, the Unemployment Insurance Fund (UIF) said on Friday – but it doesn’t have the necessary information to send them their cash.

The UIF has been rapidly paying out Covid-19 benefits under the Temporary Employer / Employee Relief Scheme (TERS), but not everything has been going smoothly.

Those employees, 220 768 of them to be precise, were either not found in the UIF system or their employers did not provide enough information for their payments to be processed, the UIF said.

On average, if eligible, each would receive around R4 200.

Employers have been sent notifications in cases where details were lacking, the UIF said.

READ MORE | More than 220 000 South Africans may be missing out on nearly R1 billion in cash, the UIF says

President Cyril Ramaphosa says he has called on the Auditor-General to put in place systems that will prevent the potential looting of billions committed to the fight against the coronavirus outbreak.

He made the comments to journalists on Friday, days after announcing a R500 billion Covid-19 relief fund, of which R20 billion will be given to municipalities.

“I do not want to hear of a commission request after this. I do not want to hear of a Covid commission, therefore we want to take proactive steps,” said Ramaphosa.

The president spent most of Friday touring some of Gauteng’s facilities, which have been prepared in response to the deadly global outbreak.

READ MORE | Ramaphosa vows Covid-19 budget will not fall prey to looting

WHAT’S HAPPENING IN THE REST OF THE WORLD 

Cases update:

For the latest global data, follow this interactive map from Johns Hopkins University & Medicine.

Late on Friday night, positive cases worldwide were close to 2.8 million, while deaths were close to 196 000.

The United States has the most cases in the world – almost 890 000, as well as the most deaths – nearly 51 000.

READ MORE | All the confirmed cases worldwide

Latest news:

Experts on Friday dismissed as reckless and irresponsible US President Donald Trump’s suggestion of injecting disinfectant to treat patients with Covid-19, the disease caused by the novel coronavirus.

“Is there a way we can do something like that, by injection inside [the body]?” Trump asked at his daily briefing on Thursday, having said that disinfectant knocks out the virus “in a minute”.

“Because, you see, it gets in the lungs and it does a tremendous number on the lungs,” Trump continued, apparently referring to disinfectant. “So it would be interesting to check that out.”

In interviews and on social networks, doctors and others dismissed Trump’s idea out-of-hand.

“This notion of injecting or ingesting any type of cleansing product into the body is irresponsible, and it’s dangerous,” Vin Gupta, pulmonologist and global health expert told NBC News.

“It’s a common method that people utilise when they want to kill themselves.”

“We have already seen people mistakenly poisoning themselves by taking chloroquine when their hopes were raised by unscientific comments,” noted Parastou Donyai, director of pharmacy practice and the University of Reading, referring to a malaria drug Trump has promoted as a treatment for Covid-19.

READ MORE | ‘Irresponsible, dangerous’ – experts trash Trump idea of injecting disinfectant to treat coronavirus

The US death toll from the coronavirus pandemic surpassed 50 000 on Friday, according to a running tally by Johns Hopkins University.

According to the tracker, 50 031 people have now died in the United States from Covid-19 since the start of the global health crisis, with more than 870 000 confirmed cases.

The United States is the hardest hit of any country in the world as the coronavirus pandemic unfolds. In the 24 hours to 00:30 GMT Friday, 3 176 people died of Covid-19, according to Johns Hopkins – one of the deadliest days recorded anywhere since the start of the pandemic.

Despite the alarming figures, several US states such as Georgia and Texas were preparing to reopen some businesses as they started lifting lockdown measures.

READ MORE | US records one of the deadliest days yet as coronavirus toll exceeds 50 000 – Johns Hopkins

LATEST RESEARCH

While most of us are doing the best we can to stay as far away from the new coronavirus as possible, some people are willing to be infected intentionally.

As scientists are racing towards the development of a vaccine against the new coronavirus, a grassroots effort has attracted nearly more than 2 300 volunteers – should they be needed for such a trial.

This controversial approach is also known as a human-challenge trial.

The programme is called 1 Day Sooner and not affiliated with any groups or companies currently developing and funding coronavirus vaccines.

READ MORE | People are volunteering to be infected with the coronavirus, in a controversial vaccine approach

While most people are anxious about the coronavirus, people with underlying conditions such as diabetes may be especially so.

Earlier, more extensive research from China published in JAMA showed a 2% fatality rate among Covid-19 patients. But this rate jumped to about 10% for those who also had cardiovascular disease and to about 7% among those with diabetes. A report from Italy found among 481 patients who died of the virus, about one-third had diabetes.

That represents a risk of death five times higher than would be expected based on diabetes’ overall prevalence in Italy, said Dr Robert Eckel, an endocrinologist at the University of Colorado School of Medicine.

While there’s much to learn about Covid-19, its course in people with diabetes appears to loosely parallel that of influenza. Outcomes are less stable, ventilators are more commonly needed, and severe complications are more likely in people with diabetes who get the flu, said Eckel, current president of medicine and science at the American Diabetes Association.

The reasons are complicated. In people with type 2 diabetes, insulin resistance gives rise to chronic, low-grade inflammation, leaving the immune system dulled by this ongoing state of alert. New infections are like “crying wolf” – the immune system does not rally quickly and adequately, therefore allowing the virus to gain and maintain a foothold.

READ MORE | Understanding the risky combination of diabetes and the coronavirus

HEALTH TIPS (as recommended by the NICD and WHO)

• Maintain physical distancing – stay at least one metre away from somebody who is coughing or sneezing

• Practise frequent hand-washing, especially after direct contact with ill people or their environment

• Avoid touching your eyes, nose and mouth, as your hands touch many surfaces and could potentially transfer the virus

• Practise respiratory hygiene – cover your mouth with your bent elbow or tissue when you cough or sneeze. Remember to dispose the tissue immediately after use.

READ MORE: Coronavirus 101 

Image credit: Getty Images

Share Button

Health24.com | Woman’s breast implant probably saved her from bullet

In a remarkable case study, a woman from Ontario, Canada, had a narrow escape after being hit by a bullet in a shooting incident.

This medical case study was first published on 15 April 2020. Breast augmentation with silicone implants remains one of the most performed operations by plastic surgeons, and in this case the silicone implant was probably responsible for deflecting the bullet’s trajectory.

The woman was walking down the street when she suddenly felt heat and pain in her left breast and saw blood when she looked down. The firearm was never recovered, and the shooter remains unknown.

She was transferred to a trauma unit, where she remained in a stable condition with only one wound where the bullet entered her body. During the examination, the medical team observed a hard, bullet-like mass on the right side of her chest. X-rays confirmed that the bullet was still lodged in her body.

Implant saved her life

The bullet entered her chest on the left side and was deflected through the right thoracic wall, where it became lodged.

The woman suffered slight damage to lung tissue and a fractured rib.

The team removed the damaged implants and then the bullet. As the left implant lay over the heart and intrathoracic cavity, it is likely that it saved the women’s life, according to the case study. The X-rays and clinical examination prove that if it weren’t for the implant, the bullet might have struck her heart.

“Based on trajectory of bullet entry clinically and evaluation radiologically, the only source of bullet deflection of the bullet is the left breast implant,” the authors stated in the report.

“This trajectory change could only have been due to the bullet hitting the implant in our patient’s case, as the bullet did not hit bone on the left side (as evidenced by lack of left-sided fracture and a bullet that retained enough energy to cause right-sided fractures).”

Image credit:

Share Button

Coronavirus: Plea for public to get medical care when they need it

People needing help should not be put off by the coronavirus pandemic, say health professionals.

Share Button

Coronavirus test website reopens for bookings after ‘significant demand’

Millions of key workers and their households can apply for a test to see if they have coronavirus.

Share Button

Climate change may push some species to higher elevations — and out of harm’s way

A new WCS-led study reveals that mountain-dwelling species fleeing warming temperatures by retreating to higher elevations may find refuge from reduced human pressure.

A new study published in Nature Communications by scientists at WCS, the University of California, Berkeley, and the United States Forest Service shows that nearly 60 percent of all mountainous area is under intense human pressure. Most of the pressure is at low elevations and mountain bases, which tend to be easier places for people to live, grow food, and build roads. The scientists then used climate models to make predictions about how species would move under climate change. Based on their predictions, they found that species tend to move to higher elevations, and that these higher elevations tend to have more intact land for species because there is less human pressure.

Without factoring in human pressure, the authors warn that conservation actions may be misguided. Factoring in human pressure reveals the true ‘shape’ of a mountain for species that are restricted to intact landscapes, which are often the species of greatest conservation concern. Here, the ‘true shape’ refers to how much land area is potentially available as habitat for a species as it moves up in elevation, not simply how much total land area is available. The true shape can reveal where species will tend to lose versus gain intact land area as they shift under climate change: the elevations where species are expected to lose area represent the priority zones for conservation.

Mountains are home to over 85 percent of the world’s amphibians, birds, and mammals, making them global conservation priorities. But mountain-dwelling species are at risk from human activities, such as agriculture, livestock grazing, and development that reduce their habitat, and climate change that threatens to push species upslope as they struggle to find tolerable temperatures.

“Species are adapted to certain temperature conditions. As temperatures warm in mountains, scientists have documented species moving to higher elevations to maintain the same temperatures,” said Paul Elsen, a WCS Climate Adaptation Scientist and lead author of the study. “This was always seen as a problem, because species would have less land area and less habitat to occupy at high elevations. But what we found is that as species move upslope, they tend to move away from areas that are already under intense human pressure and into areas with reduced human pressure. As a result, they can occupy more intact land area, even if the total amount of land area declines.”

The authors combined several global databases to make their assessments: high-resolution digital elevation models gave a picture about how much surface area is available at different elevations. The Human Footprint Index provided information on pressure from human activities. Global climate models projected how temperatures are likely to change by the late 21st century.

The authors then used computer simulations to place hundreds of thousands of hypothetical ‘species’ across all mountain ranges at different elevations and then predicted how they would shift their ranges based on climate projections. For each simulation, they compared the amount of area the species had to begin with to the amount they would have after the range shift under climate change.

Said Elsen: “We were surprised to find that many species had more intact land area available after the range shift compared to when they started.”

The results suggest that many species in mountain ranges may have more intact land area available in the future if they track warming temperatures to higher slopes, though there were exceptions.

“Our results offer a glimmer of hope for montane species under climate change,” Elsen said. “Montane species are still facing tremendous human pressure, especially at low elevations, but we have the opportunity now to protect intact habitats at higher elevations to give these species the best possible chance going forward.”

Story Source:

Materials provided by Wildlife Conservation Society. Note: Content may be edited for style and length.

Share Button

Traffic officer protein governs speed of sugar/fat conversion pathway

Scientists in Texas and Pennsylvania have identified a protein sensor that restricts how much sugar and fat our cells convert into energy during periods of starvation. It is possible, the scientists say, that the sensor could be fine-tuned to prompt more sugar and fat conversion in people with metabolic conditions such as diabetes, obesity and cardiovascular disease who need help trimming down and living a healthier lifestyle.

The study was published April 21 in the journal Science Signaling.

Senior author Madesh Muniswamy, Ph.D., from the Long School of Medicine at The University of Texas Health Science Center at San Antonio, is an expert in the function and properties of mitochondria. These are the cell structures that convert sugar and fat into chemical energy called ATP.

“We want to offer, in the future, a solution to the metabolic crisis faced by millions of people across the world,” Dr. Muniswamy said. “Millions of people consume too much food, while millions of others are in poverty and subsist on too little food. We are studying what happens at the molecular level in both situations with a goal of developing a drug to intervene.”

Speed of conversion

Our bodies continuously move things from cell to cell with what are sort of like roadways and cars. The vehicle required for fat and sugar conversion is called the mitochondrial calcium uniporter, or MCU. Like traffic moving people to destinations, the speed at which the MCU moves the energy is essential. If it is too slow, conditions such as obesity appear. If it is too fast, malnourishment results.

Driving a regulated speed limit at all times is desirable for proper health, Dr. Muniswamy said.

Keeper of the road

In the Science Signaling article, Dr. Muniswamy and colleagues describe another key component that, like a traffic police officer, regulates this roadway activity.

“We identified a mitochondrial protein called MICU1 that functions as a gatekeeper of this roadway,” Dr. Muniswamy said.

When nutrient levels are low, MICU1 clamps down on the channel activity to prevent excess energy transaction. “When you’re starving, you want to live longer, you don’t want to burn all the sugar and the fat you have, so MICU1 slows down the activity,” Dr. Muniswamy said.

The opposite is also true — if the roadway traffic is driving too slowly, MICU1 can rev it up.

Relieve conditions

“In the future, we might design a new drug to control this pathway to basically alleviate many cardiovascular- and metabolic syndrome-related diseases,” Dr. Muniswamy said. “That’s our plan.

“When you speed up the channel, all the sugar and fat will be burned, and you slim down,” he added.

Acknowledgments

The research involves multiple faculty and staff of the Department of Medicine and the Center for Renal Precision Medicine, both within the Long School of Medicine at UT Health San Antonio. Collaborators are from the Lewis Katz School of Medicine at Temple University, the Penn State University College of Medicine and Cedars-Sinai Medical Center in Los Angeles.

Coauthors in the Long School of Medicine are W. Brian Reeves, M.D.; Kumar Sharma, M.D.; Luke Norton, Ph.D.; Subramanya Srikantan, Ph.D.; Madesh Muniswamy, Ph.D.; Cassidy C. Daw; Travis R. Madaris; Karthik Ramachandran, Ph.D.; Benjamin T. Enslow; Cherubina S. Rubannelsonkumar; Soumya Maity, Ph.D.; Pragya SinghMalla; and Christopher E. Shannon, Ph.D. Dr. Muniswamy is the corresponding author. Coauthor from the School of Dentistry at UT Health San Antonio is Brij B. Singh, Ph.D.

Funding is from the National Institutes of Health and U.S. Department of Defense.

Share Button

Two steps closer to flexible, powerful, fast bioelectronic devices

Dion Khodagholy, assistant professor of electrical engineering, is focused on developing bioelectronic devices that are not only fast, sensitive, biocompatible, soft, and flexible, but also have long-term stability in physiological environments such as the human body. Such devices would greatly improve human health, from monitoring in-home wellness to diagnosing and treating neuropsychiatric diseases, including epilepsy and Parkinson’s disease. The design of current devices has been severely constrained by the rigid, non-biocompatible electronic components needed for safe and effective use, and solving this challenge would open the door to a broad range of exciting new therapies.

In collaboration with Jennifer N. Gelinas, Department of Neurology, and the Institute for Genomic Medicine at Columbia University Iriving Medical Center, Khodagholy has recently published two papers, the first in Nature Materials (March 16) on ion-driven soft and organic transistors that he and Gelinas have designed to record individual neurons and perform real-time computation that could facilitate diagnosis and monitoring of neurological disease.

The second paper, published today in Science Advances, demonstrates a soft, biocompatible smart composite — an organic mixed-conducting particulate material (MCP) — that enables the creation of complex electronic components which traditionally require several layers and materials. It also enables easy and effective electronic bonding between soft materials, biological tissue, and rigid electronics. Because it is fully biocompatible and has controllable electronic properties, MCP can non-invasively record muscle action potentials from the surface of arm and, in collaboration with Sameer Sheth and Ashwin Viswanathan at Baylor College of Medicine’s department of neurosurgery, large-scale brain activity during neurosurgical procedures to implant deep brain stimulation electrodes.

“Instead of having large implants encapsulated in thick metal boxes to protect the body and electronics from each other, such as those used in pacemakers, and cochlear and brain implants, we could do so much more if our devices were smaller, flexible, and inherently compatible with our body environment,” says Khodagholy, who directs the Translational NeuroElectronics Lab at Columbia Engineering. “Over the past several years, my group has been working to use unique properties of materials to develop novel electronic devices that allow efficient interaction with biological substrates — specifically neural networks and the brain.”

Conventional transistors are made out of silicon, so they cannot function in the presence of ions and water, and in fact break down because of ion diffusion into the device. Therefore, the devices need to be fully encapsulated in the body, usually in metal or plastic. Moreover, although they work well with electrons, they are not very effective at interacting with ionic signals, which is how the body’s cells communicate. As a result, these properties restrict the abiotic/biotic coupling to capacitive interactions only on the surface of material, resulting in lower performance. Organic materials have been used to overcome these limitations as they are inherently flexible, but the electrical performance of these devices was not sufficient to perform real-time brain signal recording and processing.

Khodagholy’s team took advantage of both the electronic and the ionic conduction of organic materials to create ion driven transistors they call e-IGTs, or enhancement-mode, internal ion-gated organic electrochemical transistors, that have embedded mobile ions inside their channels. Because the ions do not need to travel long distances to participate in the channel switching process, they can be switched on and off quickly and efficiently. The transient responses depend on electron hole rather than ion mobility, and combine with high transconductance to result in a gain-bandwidth that is several orders of magnitude above that of other ion-based transistors.

The researchers used their e-IGTs to acquire a wide range of electrophysiological signals, such as in vivo recording of neural action impulses, and to create soft, biocompatible, long-term implantable neural processing units for the real-time detection of epileptic discharges.

“We’re excited about these findings,” says Gelinas. “We’ve shown that E-IGTs offer a safe, reliable, and high-performance building block for chronically implanted bioelectronics, and I am optimistic that these devices will enable us to safely expand how we use bioelectronic devices to address neurologic disease.”

Another major advance is demonstrated by the researchers in their Science Advances paper: enabling bioelectronic devices, specifically those implanted in the body for diagnostics or therapy, to interface effectively and safely with human tissue, while also making them capable of performing complex processing. Inspired by electrically active cells, similar to those in the brain that communicate with electrical pulses, the team created a single material capable of performing multiple, non-linear, dynamic electronic functions just by varying the size and density of its composite mixed-conducting particles.

“This innovation opens the door to a fundamentally different approach to electronic device design, mimicking biological networks and creating multifunctional circuits from purely biodegradable and biocompatible components,” says Khodagholy.

The researchers design and created mixed conducting particulate (MCP)-based high performance anisotropic films, independently addressable transistors, resistors, and diodes that are pattern-free, scalable, and biocompatible. These devices carried out a variety of functions, including recording neurophysiologic activity from individual neurons, performing circuit operations, and bonding high-resolution soft and rigid electronics.

“MCP substantially reduces the footprint of neural interface devices, permitting recording of high-quality neurophysiological data even when the amount of tissue exposed is very small, and thus decreases the risk of surgical complications,” says Gelinas. “And because MCP is composed of only biocompatible and commercially available materials, it will be much easier to translate into biomedical devices and medicine.”

Both the E-IGTs and MCP hold great promise as critical components of bioelectronics, from wearable miniaturized sensors to responsive neurostimulators. The E-IGTs can be manufactured in large quantities and are accessible to a broad range of fabrication processes. Similarly, MCP components are inexpensive and easily accessible to materils scientist and engineers. In combination, they form the foundation for fully implantable biocompatible devices that can be harnessed both to benefit health and to treat disease.

Khodagholy and Gelinas are now working on translating these components into functional long-term implantable devices that can record and modulate brain activity to help patients with neurological diseases such as epilepsy.

“Our ultimate goal is to create accessible bioelectronic devices that can improve peoples’ quality of life,” says Khodagholy, “and with these new materials and components, it feels like we have stepped closer to that.”

Share Button

Catalyst opens door to more efficient, environmentally friendly ethylene production

A research team led by North Carolina State University has engineered a new catalyst that can more efficiently convert ethane into ethylene, which is used in a variety of manufacturing processes. The discovery could be used in a conversion process to drastically reduce ethylene production costs and cut related carbon dioxide emissions by up to 87%.

“Our lab previously proposed a technique for converting ethane into ethylene, and this new redox catalyst makes that technique more energy efficient and less expensive while reducing greenhouse gas emissions,” says Yunfei Gao, a postdoctoral scholar at NC State and lead author of a paper on the work. “Ethylene is an important feedstock for the plastics industry, among other uses, so this work could have a significant economic and environmental impact.”

“Ethane is a byproduct of shale gas production, and the improved efficiency of our new catalyst makes it feasible for energy extraction operations in remote locations to make better use of that ethane,” says Fanxing Li, corresponding author of the paper and an associate professor and University Faculty Scholar in NC State’s Department of Chemical Engineering.

“It is estimated that more than 200 million barrels of ethane are rejected each year in the lower 48 states due to the difficulty of transporting it from remote locations,” Li says. “With our catalyst and conversion technique, we think it would be cost effective to convert that ethane into ethylene. The ethylene could then be converted into liquid fuel, which is much easier to transport.

“The problem with current conversion techniques is that you can’t scale them down to a size that makes sense for remote energy extraction sites — but our system would work well in those locations.”

The new redox catalyst is a molten carbonate promoted mixed metal oxide, and the conversion process takes place at between 650 and 700 degrees Celsius with integrated ethane conversion and air separation. Current conversion techniques require temperatures higher than 800 degrees C.

“We estimate that the new redox catalyst and technique cut energy requirements by 60-87%,” Li says.

“Our technique would require an initial investment in the installation of new, modular chemical reactors, but the jump in efficiency and ability to convert stranded ethane would be significant,” Li says.

Story Source:

Materials provided by North Carolina State University. Note: Content may be edited for style and length.

Share Button

Fault roughness and magnitude of earthquakes

A new study led by McGill University has found that tectonic plates beneath the Earth’s surface can show varying degrees of roughness and could help explain why certain earthquakes are stronger than others.

Earthquakes happen when the rocks beneath the Earth’s surface break along geological fault lines and slide past each other. The properties of these faults — such as the roughness of their surface — can have an influence on the size of seismic events, however their study has been challenging because they are buried deep beneath the Earth’s surface.

In order to have a better understanding of the characteristics of these faults, researchers from McGill University, the University of California Santa Cruz and Ruhr University Bochum in Germany used high-resolution seismic reflection data to map and measure the roughness of 350 km2 of a plate boundary fault located off the Pacific coast of Costa Rica.

“We already knew that the roughness of a fault was an important factor, but we did not know how rough faults in the subsurface truly are, nor how variable the roughness is for a single fault,” says James Kirkpatrick, a professor in McGill’s Department of Earth and Planetary Sciences.

Rougher surfaces of faults may explain earthquake magnitude

In a recently published study in Nature Geoscience, Kirkpatrick and his colleagues were able to show that some parts of the studied fault have a rougher surface than others.

Historically, the earthquakes that have occurred in this part of the world have been moderately large (M7) and Kirkpatrick, who is also the study’s first author, believes the rough patches they found might be the reason why.

“These rough patches are stronger and more resistant to earthquake slip,” he says. “The historical record of earthquakes is relatively short, so we can’t say with certainty that larger ones have not occurred. Future seismic events in the area, which will be recorded with modern equipment, should help us determine if they show the same limited magnitude.”

Kirkpatrick and his colleagues also hope to apply their methods to other subduction zones where similar geophysical data is available to start to evaluate whether their conclusions are generally applicable.

“This connection between the fault roughness and earthquake magnitude might one day help us understand the size and style of earthquakes most likely to occur a given fault.”

Story Source:

Materials provided by McGill University. Note: Content may be edited for style and length.

Share Button